−4.69 MUSD
78.69 M
About PSYBIO THERAPEUTICS CORP
Sector
Industry
CEO
Evan M. Levine
Headquarters
Vancouver
Founded
2009
FIGI
BBG0108BFCN7
PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company was founded on October 28, 2009 and is headquartered in Vancouver, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PSYBF is 0.0075 USD — it has increased by 14.62% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PsyBio Therapeutics Corp. stocks are traded under the ticker PSYBF.
PSYBF stock is 12.75% volatile and has beta coefficient of 2.24. Check out the list of the most volatile stocks — is PsyBio Therapeutics Corp. there?
Yes, you can track PsyBio Therapeutics Corp. financials in yearly and quarterly reports right on TradingView.
PSYBF stock has fallen by 4.49% compared to the previous week, the month change is a 24.17% rise, over the last year PsyBio Therapeutics Corp. has showed a 66.89% decrease.
No, PSYBF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PSYBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PsyBio Therapeutics Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PsyBio Therapeutics Corp. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PsyBio Therapeutics Corp. stock shows the sell signal. See more of PsyBio Therapeutics Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.